Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
Main Authors: | Lund-Palau, H, Meng, C, Pilou, A, Atsumi, N, Bhargava, A, Chan, M, Byrne, A, Pringle, I, Ashworth, R, Gill, D, Hyde, S, Morgan, C, Alton, E, Griesenbach, U |
---|---|
Format: | Conference item |
Published: |
BMJ Publishing Group
2018
|
Similar Items
-
Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
by: Lund-Palau, H, et al.
Published: (2018) -
Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
by: Palau, H, et al.
Published: (2019) -
Gene therapy for pulmonary alveolar proteinosis
by: Atsumi, N, et al.
Published: (2017) -
Rare lung disease II: pulmonary alveolar proteinosis.
by: Juvet, S, et al.
Published: (2008) -
Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
by: Bystrom, J, et al.
Published: (2017)